275 related articles for article (PubMed ID: 31545407)
1. MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer.
Wang S; Huang M; Wang Z; Wang W; Zhang Z; Qu S; Liu C
Int J Oncol; 2019 Nov; 55(5):1097-1109. PubMed ID: 31545407
[TBL] [Abstract][Full Text] [Related]
2. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
Li WQ; Zhang JP; Wang YY; Li XZ; Sun L
Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561
[TBL] [Abstract][Full Text] [Related]
4. A FXYD5/TGF‑β/SMAD positive feedback loop drives epithelial‑to‑mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
Bai Y; Li LD; Li J; Chen RF; Yu HL; Sun HF; Wang JY; Lu X
Int J Oncol; 2020 Jan; 56(1):301-314. PubMed ID: 31746425
[TBL] [Abstract][Full Text] [Related]
5. miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
Liu X; Bi L; Wang Q; Wen M; Li C; Ren Y; Jiao Q; Mao JH; Wang C; Wei G; Wang Y
Oncogene; 2018 Jun; 37(25):3426-3439. PubMed ID: 29555976
[TBL] [Abstract][Full Text] [Related]
6. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
7. Role and clinical significance of TGF‑β1 and TGF‑βR1 in malignant tumors (Review).
Wang J; Xiang H; Lu Y; Wu T
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33604683
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
[TBL] [Abstract][Full Text] [Related]
10. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
11. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
Zhang L; Sun D; Zhang J; Tian Y
Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
[TBL] [Abstract][Full Text] [Related]
12. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.
Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L
Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774
[No Abstract] [Full Text] [Related]
13. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
[TBL] [Abstract][Full Text] [Related]
14. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling.
Yang G; Liang Y; Zheng T; Song R; Wang J; Shi H; Sun B; Xie C; Li Y; Han J; Pan S; Lan Y; Liu X; Zhu M; Wang Y; Liu L
Cancer Lett; 2016 Aug; 378(2):80-6. PubMed ID: 27177473
[TBL] [Abstract][Full Text] [Related]
15. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
16. MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer.
Xu J; Shao T; Song M; Xie Y; Zhou J; Yin J; Ding N; Zou H; Li Y; Zhang J
Mol Cancer; 2020 Mar; 19(1):51. PubMed ID: 32127004
[TBL] [Abstract][Full Text] [Related]
17. MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC.
Wang X; Chen X; Meng Q; Jing H; Lu H; Yang Y; Cai L; Zhao Y
Sci Rep; 2015 Dec; 5():17618. PubMed ID: 26620926
[TBL] [Abstract][Full Text] [Related]
18. miR-96-5p regulated TGF-β/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1.
Chen S; Luo Y; Cui L; Yang Q
Cell Cycle; 2020 Jul; 19(14):1740-1753. PubMed ID: 32635855
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
20. The miR-5694/AF9/Snail Axis Provides Metastatic Advantages and a Therapeutic Target in Basal-like Breast Cancer.
Tian X; Yu H; Li D; Jin G; Dai S; Gong P; Kong C; Wang X
Mol Ther; 2021 Mar; 29(3):1239-1257. PubMed ID: 33221433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
